- Formulation and bioactivity evaluation of titanium dioxide nanoparticles from Coriandrum sativum leaves extract via design of experiments. [Journal Article]Drug Dev Ind Pharm. 2026 Oct 23; :1-34. [Online ahead of print]DD
- CONCLUSIONS: Green-synthesized titanium dioxide nanoparticles exhibit effective antibacterial and antioxidant properties, demonstrating promising potential for nanotechnological applications.
- Publisher Full Text (DOI)
- Nano-Emulsification and Soft Gel Encapsulation to Improve the Delivery of Anti-Diabetic Drug Ertugliflozin-L-Pyroglutamic Acid via SNEDDS: An In Vitro Assessment using RP-HPLC. [Journal Article]Drug Dev Ind Pharm. 2026 Oct 22; :1-17. [Online ahead of print]DD
- CONCLUSIONS: The developed SNEDDS based soft gelatin capsule demonstrated favorable physicochemical characteristics and rapid in vitro dissolution of ERT, supporting its potential as an alternative lipid-based oral dosage form to the marketed tablet.
- Publisher Full Text (DOI)
- AQbD-Driven Green RP-HPLC Method Development and Validation for Simultaneous Quantification of Apremilast and Quercetin in Nanostructured Lipid Carriers. [Journal Article]Drug Dev Ind Pharm. 2026 Oct 22; :1-20. [Online ahead of print]DD
- CONCLUSIONS: The AQbD-driven green RP-HPLC method proved sensitive, robust and validated. It is suitable for the simultaneous quantification of apremilast and quercetin in nanostructured lipid carriers and related pharmaceutical applications.
- Publisher Full Text (DOI)
- Quality-by-Design-Guided Reactive Oxygen Species-Responsive Antimicrobial Nanotheranostics for Biofilm Eradication: A Translational Perspective. [Review]Drug Dev Ind Pharm. 2026 Oct 22; :1-28. [Online ahead of print]DD
- CONCLUSIONS: The integration of ROS-responsive nanotheranostics with QbD principles provides a rational strategy for developing clinically translatable antibiofilm therapies. Defining performance-linked quality attributes and robust design spaces can improve reproducibility, safety, scalability, and regulatory compliance, thereby accelerating the development of next-generation antimicrobial nanotheranostic systems for persistent biofilm-associated infections.
- Publisher Full Text (DOI)
- Harnessing the Potential of Phospholipids as Pharmaceutical Excipients: A Versatile Platform for Customized Drug Delivery Systems. [Review]Drug Dev Ind Pharm. 2026 Oct 22; :1-41. [Online ahead of print]DD
- CONCLUSIONS: Phospholipids represent a programmable excipient platform used in numerous approved lipid-based drug products. Advances in synthetic lipid engineering, AI-guided design, and personalised medicine are expected to expand their impact across gene therapy, biologics, and long-acting therapeutics.
- Publisher Full Text (DOI)
- Physicochemical characterization of a bioactive Minthostachys verticillata nanoemulsion with enhanced antibacterial efficacy against veterinary pathogens. [Journal Article]Drug Dev Ind Pharm. 2026 Oct 21; :1-48. [Online ahead of print]DD
- Antimicrobial resistance among livestock pathogens represents a growing challenge for veterinary medicine, underscoring the need for effective plant-based alternatives. This study describes the development and physicochemical characterization of an oil-in-water nanoemulsion incorporating Minthostachys verticillata essential oil (EO) and evaluates its biocompatibility and antibacterial efficacy. T…
- Publisher Full Text (DOI)
- Synthesis, characterization, and in vivo evaluation of desvenlafaxine decanoate, a new long-acting injectable antidepressant. [Journal Article]Drug Dev Ind Pharm. 2026 Oct 21; :1-9. [Online ahead of print]DD
- CONCLUSIONS: These findings support the feasibility of desvenlafaxine decanoate as a promising long-acting injectable antidepressant for patients requiring prolonged maintenance therapy.
- Publisher Full Text (DOI)
- Correction. [Journal Article]
- Publisher Full Text (DOI)
- Harnessing Functionalized Nano Lipid Carriers for Cardioprotection: Dual Drug Delivery in Focus for Precision Therapeutics. [Review]Drug Dev Ind Pharm. 2026 Oct 16; :1-22. [Online ahead of print]DD
- CONCLUSIONS: Functionalized dual drug-loaded NLCs represent a novel and promissing strategy for improving cardioprotective therapy. Their ability to enhance targeted delivery, therapeutic efficacy, and patient safety positions them as a transformative platform for future cardiovascular disease management, pending preclinical and clinical validation.
- Publisher Full Text (DOI)
- In vitro release kinetics and mathematical modeling of ribes nigrum extract-loaded PLGA/chitosan nanoparticles. [Journal Article]Drug Dev Ind Pharm. 2026 Oct 10; :1-16. [Online ahead of print]DD
- CONCLUSIONS: These findings demonstrate the value of comprehensive kinetic modeling in the design of nanoparticulate delivery systems and indicate that RN-loaded hybrid polymeric nanoparticles may be promising candidates for sustained-release mucosal delivery platforms. Further biological, stability, and in vivo studies are required to evaluate their therapeutic relevance and safety under physiologically relevant conditions.
- Publisher Full Text (DOI)
- Development and optimization of baicalin-loaded transniosomes using quality by design: dermatokinetic and in vivo efficacy evaluation. [Journal Article]Drug Dev Ind Pharm. 2026 Oct 13; :1-18. [Online ahead of print]DD
- CONCLUSIONS: The BCL-TN gel is a promising transdermal delivery platform with considerable therapeutic potential for the treatment of skin cancer.
- Publisher Full Text (DOI)
- Spotlights on cervical cancer: progression, diagnosis and clinical manifestations, epidemiology, treatment approaches, role of artificial intelligence and future directions. [Review]Drug Dev Ind Pharm. 2026 Oct 15; :1-18. [Online ahead of print]DD
- CONCLUSIONS: Cervical cancer research should focus on precision medicine, integrating recent models of artificial intelligence, advanced screening technologies, immunotherapy, and global public health initiatives. Combining these approaches could lead to improving early tumor detection, optimizing treatment outcomes, reducing disease burden, and contributing to eliminating cervical cancer.
- Publisher Full Text (DOI)
- Novel cocrystal inclusion compound of bezafibrate with l-proline: preparation, characterization, and in vitro/in vivo evaluation. [Journal Article]Drug Dev Ind Pharm. 2026 Oct 04; :1-13. [Online ahead of print]DD
- CONCLUSIONS: The prepared BEZA-L-Pro cocrystal and BEZA-L-Pro/HP-β-CD inclusion compound can significantly improve the solubility and dissolution of BEZA, and enhance its bioavailability.
- Publisher Full Text (DOI)
- Influence of infill pattern on ketoprofen release rate from 3D printed buccal films. [Journal Article]Drug Dev Ind Pharm. 2026 Oct 03; :1-14. [Online ahead of print]DD
- CONCLUSIONS: Combining filament soaking with FDM 3D printing enables fabrication of ketoprofen buccal films with sustained release. Simple infill pattern modifications effectively modulate release profiles, highlighting the potential of this accessible approach for personalized buccal drug delivery.
- Publisher Full Text (DOI)
- Design buccal film for systemic delivery of insulin. [Review]Drug Dev Ind Pharm. 2026 Oct 05; :1-24. [Online ahead of print]DD
- CONCLUSIONS: Mucoadhesive buccal films are a promising alternative for insulin administration. Future progress will likely depend on smart, stimuli-responsive formulations, especially glucose-responsive systems, and precision manufacturing approaches such as 3D printing. Clinical translation will require improved stability, permeability, standardization, and scalable production.
- Publisher Full Text (DOI)